Clinical Studies

We are investigating a new diet that may potentially induce insulin remission in cats with newly diagnosed diabetes.

We are investigating a new diet that may potentially improve glycemic control in dogs with moderately controlled diabetes.

The study aims to confirm the effectiveness and safety of a new medicine to control pain associated with osteoarthritis of the elbow in dogs. 

This study will compare certain markers in the blood that are specific to cancer, but not found in healthy dogs, before and after surgical biopsy or surgical removal of a mass.

This study will compare markers in the blood that are specific to cancer but not found in healthy dogs, before and after treatment for cancer has begun.

This study aims to evaluate changes in a specific blood hormone that has previously been related to sepsis diagnosis in canine patients surgically treated for sepsis in the abdomen and in healthy dogs with intestinal obstructions that are being surgically removed. We are investigating possible novel markers for sepsis with the goal of developing new diagnostic tests.

This study aims to determine whether or not canine patients diagnosed with canine osteosarcoma (OSA) have intestinal dysbiosis and whether treating intestinal disease improves patient outcomes.

This study seeks to understand the intestinal absorption potential of a novel formulation of rapamycin when administered to dogs with naturally occurring cancer. The data from this study will be used to define an ideal dose of the drug to use in future cancer clinical studies.

This is study is looking to develop a novel diagnostic test for canine pancreatitis through the identification of genomic markers called exosomes.